oxprenolol and colforsin

oxprenolol has been researched along with colforsin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
D'Ambrosio, D; Fabbri, L; Lang, R; Lucia, PD; Mazzeo, D; Panina-Bordignon, P; Self, C; Sinigaglia, F	1

Other Studies

1 other study(ies) available for oxprenolol and colforsin

Article	Year
Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. The Journal of clinical investigation, 1997, Sep-15, Volume: 100, Issue:6 Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adult; Albuterol; Bucladesine; Cell Differentiation; Colforsin; Cyclic AMP; Dendritic Cells; Dose-Response Relationship, Drug; Humans; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-12; Interleukin-6; Lipopolysaccharides; Macrophages; Oxprenolol; RNA, Messenger; Th1 Cells; Th2 Cells; Tumor Necrosis Factor-alpha	1997

Article

Year

Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

The Journal of clinical investigation, 1997, Sep-15, Volume: 100, Issue:6

Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adult; Albuterol; Bucladesine; Cell Differentiation; Colforsin; Cyclic AMP; Dendritic Cells; Dose-Response Relationship, Drug; Humans; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-12; Interleukin-6; Lipopolysaccharides; Macrophages; Oxprenolol; RNA, Messenger; Th1 Cells; Th2 Cells; Tumor Necrosis Factor-alpha

1997